News

Video

Updates in First-Line Systemic Therapy for Advanced HCC: The HIMALAYA Study

Author(s):

Rachna T. Shroff, MD, MS, FASCO, University of Arizona Cancer Center ,Manish Shah, MD

Dr Manish Shah reviews data from the HIMALAYA study on front-line systemic therapy in advanced HCC with tremelimumab plus durvalumab.

Related Videos
Related Content